{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:36:55Z","timestamp":1792100215076,"version":"4.4.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1053230"],"award-info":[{"award-number":["OPP1053230"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13071-018-2670-6","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T12:00:54Z","timestamp":1517227254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Helminth lifespan interacts with non-compliance in reducing the effectiveness of anthelmintic treatment"],"prefix":"10.1186","volume":"11","author":[{"given":"Sam H.","family":"Farrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"key":"2670_CR1","unstructured":"World Health Organisation. Accelerating work to overcome the global impact of neglected tropical diseases : a roadmap for implementation : executive summary. 2012. \n                    http:\/\/apps.who.int\/iris\/handle\/10665\/70809\n                    \n                  . Accessed 17 Nov 2017."},{"key":"2670_CR2","unstructured":"World Health Organisation. Helminth control in school age children: a guide for managers of control programmes - 2nd ed. 2011. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/44671\/1\/9789241548267_eng.pdf\n                    \n                  . Accessed 17 Nov 2017."},{"key":"2670_CR3","unstructured":"World Health Organisation. Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups. 2017. \n                    http:\/\/apps.who.int\/iris\/handle\/10665\/258983\n                    \n                  . Accessed 17 Nov 2017."},{"issue":"10","key":"2670_CR4","doi-asserted-by":"publisher","first-page":"e008950","DOI":"10.1136\/bmjopen-2015-008950","volume":"5","author":"SJ Brooker","year":"2015","unstructured":"Brooker SJ, Mwandawiro CS, Halliday KE, Njenga SM, Mcharo C, Gichuki PM, et al. Interrupting transmission of soil-transmitted helminths: a study protocol for cluster randomised trials evaluating alternative treatment strategies and delivery systems in Kenya. BMJ Open. 2015;5(10):e008950.","journal-title":"BMJ Open"},{"issue":"5","key":"2670_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/QCO.0000000000000395","volume":"30","author":"KH \u00c1sbj\u00f6rnsd\u00f3ttir","year":"2017","unstructured":"\u00c1sbj\u00f6rnsd\u00f3ttir KH, Means AR, Werkman M, Walson JL. Prospects for elimination of soil-transmitted helminths. Curr Opin Infect Dis. 2017;30(5):482\u20138.","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"2670_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1046\/j.1365-3156.2001.00682.x","volume":"6","author":"P Esterre","year":"2001","unstructured":"Esterre P, Plichart C, Sechan Y. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Tropical Med Int Health. 2001;6(3):190\u20135.","journal-title":"Tropical Med Int Health"},{"key":"2670_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13071-016-1311-1","volume":"9","author":"KV Shuford","year":"2016","unstructured":"Shuford KV, Turner HC, Anderson RM. Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review. Parasit Vectors. 2016;9:29.","journal-title":"Parasit Vectors"},{"key":"2670_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13071-017-2206-5","volume":"10","author":"SH Farrell","year":"2017","unstructured":"Farrell SH, Truscott J, Anderson R. The importance of patient compliance in repeated rounds of drug treatment for elimination of intestinal helminths. Parasit Vectors. 2017;10:291.","journal-title":"Parasit Vectors"},{"key":"2670_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/bs.apar.2016.06.003","volume":"94","author":"RM Anderson","year":"2016","unstructured":"Anderson RM, Turner HC, Farrell SH, Truscott JE. Studies of the transmission dynamics, mathematical model development and the control of schistosome parasites by mass drug administration in human communities. Adv Parasitol. 2016;94:199\u2013246.","journal-title":"Adv Parasitol"},{"key":"2670_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1017\/S0031182000052288","volume":"90","author":"R Anderson","year":"1985","unstructured":"Anderson R, Medley G. Community control of helminth infections of man by mass and selective chemotherapy. Parasitology. 1985;90:629\u201360.","journal-title":"Parasitology"},{"key":"2670_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.apar.2016.08.002","volume":"94","author":"JE Truscott","year":"2016","unstructured":"Truscott JE, Turner HC, Farrell SH, Anderson RM. Soil-transmitted helminths: mathematical models of transmission, the impact of mass drug administration and transmission elimination criteria. Adv Parasitol. 2016;94:133\u201398.","journal-title":"Adv Parasitol"},{"key":"2670_CR12","volume-title":"Infectious diseases of humans: dynamics and control","author":"R Anderson","year":"1992","unstructured":"Anderson R, May R. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1992."},{"issue":"3","key":"2670_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S0031182000080896","volume":"110","author":"AJ Fulford","year":"1995","unstructured":"Fulford AJ, Butterworth AE, Ouma JH, Sturrock RF. A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man. Parasitology. 1995;110(3):307\u201316.","journal-title":"Parasitology"},{"key":"2670_CR14","unstructured":"World Health Organisation. Adherence to long-term therapies : evidence for action. 2003. \n                    http:\/\/apps.who.int\/iris\/handle\/10665\/42682\n                    \n                  . Accessed 17 Nov 2017."},{"key":"2670_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s12936-016-1593-y","volume":"15","author":"B Adhikari","year":"2016","unstructured":"Adhikari B, James N, Newby G, von Seidlein L, White NJ, NPJ D, et al. Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review. Malar J. 2016;15:523.","journal-title":"Malar J"},{"key":"2670_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0065-308X(04)58004-1","volume":"58","author":"S Brooker","year":"2004","unstructured":"Brooker S, Bethony J, Hotez PJ. Human hookworm infection in the 21st century. Adv Parasitol. 2004;58:197\u2013288.","journal-title":"Adv Parasitol"},{"key":"2670_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s13071-015-1152-3","volume":"8","author":"MA Irvine","year":"2015","unstructured":"Irvine MA, Reimer LJ, Njenga SM, Gunawardena S, Kelly-Hope L, Bockarie M, et al. Modelling strategies to break transmission of lymphatic filariasis - aggregation, adherence and vector competence greatly alter elimination. Parasit Vectors. 2015;8:547.","journal-title":"Parasit Vectors"},{"key":"2670_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.epidem.2017.02.002","volume":"18","author":"L Dyson","year":"2017","unstructured":"Dyson L, Stolk WA, Farrell SH, Hollingsworth DT. Measuring and modelling the effects of systematic non-adherence to mass drug administration. Epidemics. 2017;18:56\u201366.","journal-title":"Epidemics"},{"issue":"7","key":"2670_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0169-4758(00)01691-4","volume":"16","author":"AP Plaisier","year":"2000","unstructured":"Plaisier AP, Stolk WA, van Oortmarssen GJ, Habbema JDF. Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection. Parasitol Today. 2000;16(7):298\u2013302.","journal-title":"Parasitol Today"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2670-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-018-2670-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2670-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:01:48Z","timestamp":1589547708000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-018-2670-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2670"],"URL":"https:\/\/doi.org\/10.1186\/s13071-018-2670-6","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]},"assertion":[{"value":"23 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Roy Anderson is a Non-Executive Director of GlaxoSmithKline (GSK). GSK had no role in the funding of this research or this publication. Sam Farrell declares that he has no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"66"}}